文献速递神经肿瘤

5-氨基乙酰丙酸术中标记胶质母细胞瘤特异性的单细胞分析

Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.
PubMed 文献 · J Neurosurg · 2023-09-22

本研究采用单细胞光学表型分析与表达测序第2版(SCOPE-seq2)对接受5-氨基乙酰丙酸(5-ALA)后手术的胶质母细胞瘤(GBM)标本进行单细胞成像与RNA测序,发现5-ALA标记并非肿瘤细胞特异,非肿瘤细胞可直接摄取5-ALA或被周围肿瘤细胞分泌的原卟啉IX(PpIX)标记;小鼠胶质瘤急性切片培养显示5-ALA优先标记肿瘤组织而非正常脑组织,肿瘤边缘有显著标记,且该对比并非血脑屏障破坏所致。结论支持5-ALA作为GBM组织指示剂,但质疑其用于荧光引导手术中特异性细胞内标记肿瘤细胞的主要优势,需进一步研究系统比较5-ALA与潜在替代方案。

要点

  • SCOPE-seq2分析人GBM手术标本显示5-ALA标记并非肿瘤细胞特异。
  • 非肿瘤细胞可直接被5-ALA标记或被周围肿瘤细胞分泌的PpIX标记。
  • 小鼠胶质瘤切片中5-ALA优先标记肿瘤组织,边缘显著,与血脑屏障破坏无关。

核心结论

  • 研究结果支持5-ALA作为GBM组织的指示剂,但质疑其在荧光引导手术中特异性细胞内标记肿瘤细胞的主要优势。
  • 需要进一步研究系统比较5-ALA与潜在替代方案在荧光引导手术中的表现。

研究设计与样本

  • 研究采用单细胞光学表型分析与表达测序第2版(SCOPE-seq2),一种配对单细胞成像与RNA测序方法,对接受5-ALA后手术、肉眼可见PpIX荧光的人GBM手术标本中的单个细胞进行分析。
  • 同时进行胶质瘤细胞培养和共培养模型实验,以及小鼠胶质瘤模型急性切片培养实验,以探究5-ALA和PpIX的细胞和组织特异性摄取与分泌。

主要发现

  • SCOPE-seq2分析人GBM手术标本显示5-ALA治疗导致的标记并非肿瘤胶质细胞特异。
  • 细胞培养进一步证明非肿瘤细胞可被5-ALA直接标记,或被周围肿瘤细胞分泌的PpIX标记。
  • 小鼠胶质瘤模型急性切片培养显示5-ALA优先标记GBM肿瘤组织而非非肿瘤脑组织,肿瘤边缘有显著标记,且该对比并非由于血脑屏障破坏。

局限性

  • 需要进一步研究系统比较5-ALA与潜在替代方案在荧光引导手术中的表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor, and resection is a key part of the standard of care. In fluorescence-guided surgery (FGS), fluorophores differentiate tumor tissue from surrounding normal brain. The heme synthesis pathway converts 5-aminolevulinic acid (5-ALA), a fluorogenic substrate used for FGS, to fluorescent protoporphyrin IX (PpIX). The resulting fluorescence is believed to be specific to neoplastic glioma cells, but this specificity has not been examined at a single-cell level. The objective of this study was to determine the specificity with which 5-ALA labels the diversity of cell types in GBM. METHODS: The authors performed single-cell optical phenotyping and expression sequencing-version 2 (SCOPE-seq2), a paired single-cell imaging and RNA sequencing method, of individual cells on human GBM surgical specimens with macroscopically visible PpIX fluorescence from patients who received 5-ALA prior to surgery. SCOPE-seq2 allowed the authors to simultaneously image PpIX fluorescence and unambiguously identify neoplastic cells from single-cell RNA sequencing. Experiments were also conducted in cell culture and co-culture models of glioma and in acute slice cultures from a mouse glioma model to investigate cell- and tissue-specific uptake and secretion of 5-ALA and PpIX. RESULTS: SCOPE-seq2 analysis of human GBM surgical specimens revealed that 5-ALA treatment resulted in labeling that was not specific to neoplastic glioma cells. The cell culture further demonstrated that nonneoplastic cells could be labeled by 5-ALA directly or by PpIX secreted from surrounding neoplastic cells. Acute slice cultures from mouse glioma models showed that 5-ALA preferentially labeled GBM tumor tissue over nonneoplastic brain tissue with significant labeling in the tumor margins, and that this contrast was not due to blood-brain barrier disruption. CONCLUSIONS: Together, these findings support the use of 5-ALA as an indicator of GBM tissue but question the main advantage of 5-ALA for specific intracellular labeling of neoplastic glioma cells in FGS. Further studies are needed to systematically compare the performance of 5-ALA to that of potential alternatives for FGS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Liu Z, Mela A, Argenziano MG, et al. Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma. J Neurosurg. 2023. PMID: 37773782. doi:10.3171/2023.7.JNS23122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。